Douglas C. Bryant's most recent trade in QuidelOrtho Corporation was a trade of 46,254 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 8, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Bryant Douglas C. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 46,254 | 46,254 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | C. Bryant Douglas | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 3,795 | 551,339 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,795 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | C. Bryant Douglas | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.34 per share. | 01 Feb 2024 | 1,924 | 549,415 (1%) | 0% | 68.3 | 131,486 | Common Stock |
| QuidelOrtho Corporation | Bryant Douglas C. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 1,116 | 1,116 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Bryant Douglas C. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 1,116 | 548,110 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.45 per share. | 01 Feb 2024 | 566 | 547,544 (1%) | 0% | 69.5 | 39,309 | Common Stock |
| QuidelOrtho Corporation | Bryant Douglas C. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 12,093 | 551,948 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Bryant Douglas C. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 12,093 | 12,094 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | C. Bryant Douglas | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 6,761 | 13,522 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 6,761 | 542,331 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | C. Douglas Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.51 per share. | 31 Jan 2024 | 4,954 | 546,994 (1%) | 0% | 68.5 | 339,399 | Common Stock |
| QuidelOrtho Corporation | Bryant C. Douglas | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.51 per share. | 31 Jan 2024 | 2,476 | 539,855 (1%) | 0% | 68.5 | 169,631 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 1,461 | 536,295 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2023 | 1,461 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.33 per share. | 24 Aug 2023 | 725 | 535,570 (1%) | 0% | 78.3 | 56,789 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 31,028 | 31,028 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 31,027 | 31,027 | - | - | Non-Qualified Stock Option | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 10,656 | 10,656 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 3,273 | 3,273 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 15,180 | 542,070 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.71 per share. | 23 Feb 2023 | 7,527 | 534,543 (1%) | 0% | 88.7 | 667,720 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 7,309 | 0 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2023 | 7,309 | 529,238 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.50 per share. | 11 Feb 2023 | 3,453 | 525,785 (1%) | 0% | 86.5 | 298,685 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,192 | 0 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2023 | 2,192 | 527,977 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.50 per share. | 11 Feb 2023 | 1,087 | 526,890 (1%) | 0% | 86.5 | 94,026 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 18,720 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 18,720 | 531,211 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.70 per share. | 03 Feb 2023 | 9,282 | 521,929 (1%) | 0% | 89.7 | 832,595 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 3,795 | 514,373 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 3,795 | 3,795 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.70 per share. | 03 Feb 2023 | 1,882 | 512,491 (1%) | 0% | 89.7 | 168,815 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 6,760 | 20,283 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 6,760 | 513,422 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 31 Jan 2023 | 3,406 | 510,016 (1%) | 0% | 85.6 | 291,588 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 1,115 | 2,232 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 1,115 | 511,131 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.51 per share. | 31 Jan 2023 | 553 | 510,578 (1%) | 0% | 88.5 | 48,946 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 1,460 | 1,461 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2022 | 1,460 | 507,386 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.80 per share. | 24 Aug 2022 | 724 | 506,662 (1%) | 0% | 85.8 | 62,119 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 10,222 | 10,222 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 3,140 | 3,140 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 505,926 | 505,926 (1%) | 1% | - | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 505,926 | 0 (0%) | 1% | - | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 37,440 | 37,440 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 37,440 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 30,358 | 30,358 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 30,358 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 27,637 | 27,637 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 27,637 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 27,043 | 27,043 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 27,043 | 27,043 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 27,043 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 27,043 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 24,187 | 24,187 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 24,187 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 23,461 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 23,461 | 23,461 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 20,249 | 20,249 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 20,249 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 18,720 | 18,720 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 18,720 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 11,140 | 11,140 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 11,140 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 10,593 | 10,593 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 10,593 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 8,924 | 8,924 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 8,924 | 0 | - | - | Non-Qualified Stock Options | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 7,590 | 7,590 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 7,590 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 7,309 | 7,309 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 7,309 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 3,347 | 3,347 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 3,347 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,921 | 2,921 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,921 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,646 | 2,646 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,646 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,192 | 2,192 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 2,192 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 794 | 794 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 May 2022 | 794 | 0 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 3,795 | 507,808 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 3,795 | 507,808 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 3,795 | 7,590 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 3,795 | 7,590 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.68 per share. | 03 Feb 2022 | 1,882 | 505,926 (1%) | 0% | 99.7 | 187,598 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.68 per share. | 03 Feb 2022 | 1,882 | 505,926 (1%) | 0% | 99.7 | 187,598 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 27,043 | 27,043 | - | - | Non-Qualified Stock Option | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 27,043 | 27,043 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 24,187 | 24,187 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 2,646 | 2,646 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 1,115 | 504,566 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 1,115 | 3,347 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 794 | 794 | - | - | Restricted Stock Units (Premium) | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.32 per share. | 31 Jan 2022 | 553 | 504,013 (1%) | 0% | 102.3 | 56,583 | Common Stock |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 13,819 | 510,362 (1%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Douglas C. Bryant | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2022 | 13,819 | 0 | - | - | Restricted Stock Units |